Major Pharmaceuticals

Frequent Recalls

12

Recalls

0

Units Recalled

0

Injuries

0

Deaths

Categories: Drug

2026-07-29 to 2026-07-29

Date	Source	Product	Brand	Severity	Units
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per car	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per c	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per c	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per c	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per c	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per c	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per c	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per car	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters per car	Major Pharmaceuticals	Class II	N/A
2026-07-29	FDA Drug	FDA Recall: Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 unit dose blisters) per	Major Pharmaceuticals	Class II	N/A

Major Pharmaceuticals Recalls | WatchRecall